Bakuchiol is attracting increasing attention for its efficacy against wrinkles and skin imperfections, with an additional advantage: its gentleness. Some even highlight its beneficial effects on rosacea-prone skin, particularly in soothing redness. But are these claims substantiated? Discover what the science says about the benefits of bakuchiol for reactive, rosacea-prone skin.
Rosacea: can bakuchiol attenuate redness?
Published on July 21, 2025, by Pauline, Chemical Engineer — 7 min of reading
Themes:
Can bakuchiol exert an effect on rosacea?
The rosacea is a chronic inflammatory skin disease characterised by the diffuse redness it causes on the face. It is a progressive dermatosis with flare-up periods. The causes of this condition are many and include genetics, high temperatures, stress… Initially, the rosacea often manifests as dilation of the facial blood vessels, i.e. telangiectasia, often accompanied by tingling and hot flushes. It is important to manage rosacea from the outset because it can progress to more severe forms (ocular rosacea, rhinophyma...). If it is not yet possible to cure the rosacea, there are solutions to reduce facial redness and improve patients’ quality of life.
The management of mild rosacea generally consists of applying creams containing vasoconstrictive active ingredients, such as brimonidine, anti-inflammatory agents, such as the azelaic acid, and antiparasitic agents, such as metronidazole.
With regard to the effect of bakuchiol on rosacea, this has been scarcely studied. Nevertheless, a pilot study led by DRAELOS provides interesting insights. This research assessed the tolerance of a formulation containing 1% bakuchiol in a cohort of 60 individuals, of whom 20 suffered from rosacea, 20 had eczema and 20 reported reactive skin. Over four weeks, participants applied the product daily, while several skin parameters were evaluated using a scale from 0 (none) to 4 (severe). Assessment criteria included visual and tactile smoothness, clarity of skin tone, radiance, overall skin appearance and signs of photoageing. Potential adverse effects, such as flaking, dryness or sensations of burning or itching, were also recorded using the same scale. Instrumental measurements complemented this clinical evaluation. Transepidermal water loss (TEWL) was measured using an evaporimeter, whereas skin hydration was assessed by corneometry.
Among participants with rosacea, no adverse reactions were observed throughout the study period. Furthermore, TEWL values remained stable between the start and end of the study, indicating no disruption of the skin barrier, a crucial and challenging aspect for sensitive skin. Finally, corneometry measurements revealed a statistically significant 16% increase in hydration. Although this rise may appear modest, the researchers considered it noteworthy in light of the participants’ pronounced cutaneous sensitivity. Moreover, all evaluated parameters (complexion radiance, photoageing, etc.) improved, as shown in the graph below. It is, however, unfortunate that the erythema, the persistent redness typical of rosacea, was not measured, despite being one of the key criteria for assessing the efficacy of a treatment designed for rosacea-prone skin.
Effects of bakuchiol on a panel of sensitive skin types (one-third eczema, one-third rosacea, one-third reactive skin).
Source: DRAELOS Z. D. et al. Clinical evaluation of a nature-based bakuchiol anti-ageing moisturiser for sensitive skin. Journal of Drugs in Dermatology (2020).
Although bakuchiol seems to be well tolerated by rosacea-prone skin, yet no evidence to date demonstrates that it reduces the characteristic redness of this dermatological condition.
It can nevertheless be assumed that the anti-inflammatory properties of bakuchiol could help to soothe rosacea flare-ups, thereby reducing visible redness. Indeed, several in vitro studies have shown that bakuchiol can modulate the production of pro-inflammatory mediators. Research on murine macrophages stimulated with interferon-γ revealed a significant reduction in the expression of inducible nitric oxide synthase in the presence of bakuchiol. This enzyme serves to activate macrophages during inflammation. Bakuchiol’s effect is believed to result from its capacity to inhibit the nuclear transcription factor NF-κB, a key regulator of the immune response. Once activated, NF-κB induces the production of several pro-inflammatory cytokines, including interleukin-6, which is overexpressed in rosacea-prone skin. Consequently, bakuchiol may help limit the intensity of rosacea flare-ups.
However, even though bakuchiol exhibits potentially interesting anti-inflammatory properties against rosacea, there is no evidence that it can act on vasodilation or parasites Demodex, two elements in the pathogenesis of this condition. In cases of rosacea, it is essential to consult a dermatologist to receive appropriate care and prevent the disease from worsening.
Sources
DRAELOS Z. D. & al. Clinical evaluation of a nature-based bakuchiol anti-aging moisturizer for sensitive skin. Journal of Drugs in Dermatology (2020).
VAN DER LINDEN M. & al. Rosacea: New concepts in classification and treatment. American Journal of Clinical Dermatology (2021).
SODHA P. & al. The use of bakuchiol in dermatology: a review of in vitro and in vivo evidence. Journal of Drugs in Dermatology (2022).
ZHANG T. & al. Unveiling a novel in-vitro model of skin inflammaging. Frontiers in Medicine (2025).
